Use of R-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain

Details for Australian Patent Application No. 2004212327 (hide)

Owner Novartis AG

Inventors Fox, Alyson; Bevan, Stuart

Agent Davies Collison Cave

Pub. Number AU-A-2004212327

PCT Pub. Number WO2004/071513

Priority 0303615.9 17.02.03 GB

Filing date 16 February 2004

Wipo publication date 26 August 2004

International Classifications

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 025/02 Drugs for disorders of the nervous system

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/071513 Priority application(s): WO2004/071513

31 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212328-Use of S-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders

2004212324-Albumin solution and method for the production thereof